(Q48022826)

English

Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants

scientific article published in February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

adaptive radiation therapy

0 references

author name string

Eric M Horwitz

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Raj K Mitra

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Robert G Uzzo

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Indra J Das

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Wayne H Pinover

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Alexandra L Hanlon

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Shawn W McNeeley

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Gerald E Hanks

8

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Radiotherapy and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

66

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

173-179

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Isotope selection for patients undergoing prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential role of various dosimetric quality indicators in prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reference dose rates for single- and double-plane 1 9 2 Ir implants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Individual Comparisons by Ranking Methods

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

CT-based dosimetry for transperineal I-125 prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900387-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0167-8140(02)00387-0

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12648789

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48022826&oldid=2196745898"